Training Health Promotion Women Community Leaders
Womens Leadership Intervention Program
1 other identifier
interventional
150
1 country
1
Brief Summary
Goal of the Program: To develop personal and group ability for participants in the DPP to plan and implement health promotion programs. Objectives:
- 1.Develop skills in the planning, implementation, and assessment of community-based health promotion programs
- 2.Personal, group and community capacity development in health promotion
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
March 1, 2020
CompletedFirst Posted
Study publicly available on registry
August 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 25, 2023
April 1, 2023
7 years
March 1, 2020
April 23, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Program implementation
Three programs will be implemented by the group within 12 months of initiation of the course.
12 months after completion of the course
RE-AIM assessment of intervention quality
The RE-AIM assessment tool assesses Reach, Effectiveness, Adoption, Implementation, and Maintenance of the intervention programs. Each domain is assessed by questions adapted from the RE-AIM framework. Each item is scored as fully implemented, partially implemented or not implemented, with 0 as not, 0.5 as partially and 1.0 as fully, The questions for each item are averaged for a score that ranges from 0-1, with one being full implementation
12 months after completion of the course
Secondary Outcomes (1)
health promotion leadership self efficacy
upon completion of the course, approximately 14 weeks after initiating the intervention.
Study Arms (1)
Training community health promotion leaderss
EXPERIMENTALCommunity women are trained in leadership and community-based health promotion skills
Interventions
In the leadership program, women were taught more about the manner in which to bring about a change in one's health by adapting a healthy life style, leadership and facilitation skills and the development, implementation and evaluation process required to conduct a community program that will impact society. Women learned how to map needs and resources, define goals and objectives, develop, implement and evaluate a community based program.
Eligibility Criteria
You may qualify if:
- had to previously take part in the previously implemented diabetes prevention program (DPP)
- had to have interest and ability in developing programs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hadassah Medical Organizationlead
- Jerusalem Municipalitycollaborator
Study Sites (1)
Hadassah Medical Organization
Jerusalem, 91120, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Donna Zwas, MD MPH
Hadassah Medical Organization
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Linda Joy Pollin Cardiovascular Wellness Center for Women
Study Record Dates
First Submitted
March 1, 2020
First Posted
August 6, 2020
Study Start
September 1, 2018
Primary Completion
August 31, 2025
Study Completion
December 31, 2025
Last Updated
April 25, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share
deidentified data may be shared upon reasonable investigator request